Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest
NCT07890610
Summary
This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of this study is to evaluate the physiologic response to epinephrine as an outcome discriminator in pediatric in-hospital cardiac arrest (IHCA). In addition, the investigators will determine optimal epinephrine dosing strategies based on the initial physiologic response to epinephrine, and to develop machine learning (ML) algorithms to guide intra-arrest therapy.
Eligibility
Inclusion Criteria: * Arrest in an ICU * Patients received chest compressions for at least 1 minute Exclusion Criteria: * Lack of commitment to aggressive therapies (e.g., CPR performed as part of end-of-life care) * Brain death determination prior to CPR * Out-of-hospital cardiac arrest was the reason for initial admission to the hospital (known poor outcomes) * Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation at the start of CPR
Conditions2
Locations22 sites
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07890610